Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1396 AL 1410

Behavioural aspects of a modified crosstalk between basal ganglia and limbic system in Parkinson's disease

Gyorfi O, Nagy H, Bokor M, Keri S.

Neuropsychopharmacol Hung. 2016 Jun;18(2):87-92.

Measures used for the evaluation of balance in individuals with Parkinson's disease: a systematic review

Lopes JB, Lameira de Melo GE, Lazzari RD, Santos CA, Franco de Moura RC, Dumont AJ, Braun LA, Duarte NA, Pareira RB, Miziara IM, Oliveira CS.

J Phys Ther Sci. 2016 Jun;28(6):1936-42. doi: 10.1589/jpts.28.1936. Epub 2016 Jun 28.

Base rate comparison of suboptimal scores on the RBANS effort scale and effort index in Parkinson's disease

Carter KR, Scott JG, Adams RL, Linck J.

Clin Neuropsychol. 2016 Oct;30(7):1118-25. doi: 10.1080/13854046.2016.1206145. Epub 2016 Jul 8.

[Cognitive Behavioral Therapy for Anxiety and Depression in Patients with Parkinson's Disease]

Hadinia A, Meyer A, Nowak K, Nyberg E, Fuhr P, Stieglitz RD, Gschwandtner U.

Fortschr Neurol Psychiatr. 2016 Jun;84(6):336-43. doi: 10.1055/s-0042-105762. Epub 2016 Jul 8.

Long-term double-blinded unilateral pedunculopontine area stimulation in Parkinson's disease

Mestre TA, Sidiropoulos C, Hamani C, Poon YY, Lozano AM, Lang AE, Moro E.

Mov Disord. 2016 Oct;31(10):1570-1574. doi: 10.1002/mds.26710.

The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review

Xiong WX, Sun YM, Guan RY, Luo SS, Chen C, An Y, Wang J, Wu JJ.

J Neurol. 2016 Oct;263(10):1984-92. doi: 10.1007/s00415-016-8213-1. Epub 2016 Jul 8.

Therapeutic Potential of Genipin in Central Neurodegenerative Diseases

Li Y, Li L, Hölscher C.

CNS Drugs. 2016 Oct;30(10):889-97. doi: 10.1007/s40263-016-0369-9.

Parkinson's Disease, Diabetes and Cognitive Impairment

Ashraghi MR, Pagano G, Polychronis S, Niccolini F, Politis M.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):11-21. doi: 10.2174/1872214810999160628105549.

Metallo-pathways to Alzheimer's disease: lessons from genetic disorders of copper trafficking

Greenough MA, Ramírez Munoz A, Bush AI, Opazo CM.

Metallomics. 2016 Sep 1;8(9):831-9. doi: 10.1039/c6mt00095a. Epub 2016 Jul 11.

(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study

Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C; SCILLA Working Group.

Ann Neurol. 2016 Sep;80(3):368-78. doi: 10.1002/ana.24717. Epub 2016 Aug 2.

Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease: A PRISMA-compliant systematic review and meta-analysis

Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG.

Medicine (Baltimore). 2016 Jul;95(27):e4147. doi: 10.1097/MD.0000000000004147.

Short-Term Effects of a Gain-Focused Reappraisal Intervention for Dementia Caregivers: A Double-Blind Cluster-Randomized Controlled Trial

Cheng ST, Fung HH, Chan WC, Lam LC.

Am J Geriatr Psychiatry. 2016 Sep;24(9):740-50. doi: 10.1016/j.jagp.2016.04.012. Epub 2016 Apr 29.

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

Leuzy A, Chiotis K, Hasselbalch SG, Rinne JO, de Mendonça A, Otto M, Lleó A, Castelo-Branco M, Santana I, Johansson J, Anderl-Straub S, von Arnim CA, Beer A, Blesa R, Fortea J, Herukka SK, Portelius E, Pannee J, Zetterberg H, Blennow K, Nordberg A.

Brain. 2016 Sep;139(Pt 9):2540-53. doi: 10.1093/brain/aww160. Epub 2016 Jul 7.

Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study

Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A, Linse K, Schneider C, Gräber S, Liepelt-Scarfone I, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Mollenhauer B, Trenkwalder C, Spottke A, Roeske S, Wittchen HU, Riedel O, Dodel R.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1099-105. doi: 10.1136/jnnp-2016-313838. Epub 2016 Jul 8.

Hypersexuality induced by rasagiline in monotherapy in Parkinson's disease

Simonet C, Fernández B, Cerdán DM, Duarte J.

Neurol Sci. 2016 Nov;37(11):1889-1890. doi: 10.1007/s10072-016-2668-9. Epub 2016 Jul 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias